These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26874268)

  • 41. Growth hormone response to clonidine in untreated depressed patients.
    Schittecatte M; Charles G; Machowski R; Wilmotte J
    Psychiatry Res; 1989 Aug; 29(2):199-206. PubMed ID: 2798598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of single and short-term administration of clonidine on hypothalamic-pituitary somatotropic function of the adult male rat: an in situ hybridization study.
    De Gennaro Colonna V; Zoli M; Settembrini BP; Ciceri S; De Marco A; Cella SG; Agnati LF; Muller EE
    J Pharmacol Exp Ther; 1996 Feb; 276(2):795-800. PubMed ID: 8632352
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of electroconvulsive therapy and desipramine on neuroendocrine responses to the clonidine challenge test.
    Coote M; Wilkins A; Werstiuk ES; Steiner M
    J Psychiatry Neurosci; 1998 May; 23(3):172-8. PubMed ID: 9595891
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suppression of the growth hormone (GH) response to clonidine and GH-releasing hormone by exogenous GH.
    Nakamoto JM; Gertner JM; Press CM; Hintz RL; Rosenfeld RG; Genel M
    J Clin Endocrinol Metab; 1986 May; 62(5):822-6. PubMed ID: 3082919
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative effect of clonidine and growth hormone (GH)-releasing hormone on GH secretion in adult patients on chronic glucocorticoid therapy.
    Giustina A; Buffoli MG; Bussi AR; Doga M; Girelli A; Pizzocolo G; Pozzi A; Wehrenberg WB
    Horm Metab Res; 1992 May; 24(5):240-3. PubMed ID: 1398465
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Growth hormone response to clonidine in the nervous pointer dog model of anxiety.
    Uhde TW; Malloy LC; Benson BB
    Anxiety; 1994; 1(2):45-9. PubMed ID: 9160547
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blunted growth hormone response to clonidine in Gilles de la Tourette syndrome.
    Müller N; Putz A; Klages U; Hofschuster E; Straube A; Ackenheil M
    Psychoneuroendocrinology; 1994; 19(4):335-41. PubMed ID: 8047638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuroendocrine correlates of antisocial personality disorder in abstinent heroin-dependent subjects.
    Gerra G; Zaimovic A; Moi G; Bussandri M; Delsignore R; Caccavari R; Brambilla F
    Addict Biol; 2003 Mar; 8(1):23-32. PubMed ID: 12745412
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Personality disorders, history of trauma, and posttraumatic stress disorder in subjects with anxiety disorders.
    Shea MT; Zlotnick C; Dolan R; Warshaw MG; Phillips KA; Brown P; Keller MB
    Compr Psychiatry; 2000; 41(5):315-25. PubMed ID: 11011826
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Noradrenergic function in pathological gambling: blunted growth hormone response to clonidine.
    Pallanti S; Bernardi S; Allen A; Chaplin W; Watner D; DeCaria CM; Hollander E
    J Psychopharmacol; 2010 Jun; 24(6):847-53. PubMed ID: 19028836
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Growth rate and growth hormone response to growth hormone-releasing hormone challenge in slowly growing children during chronic administration of clonidine.
    Orio F; Padovano N; Cinquanta L; Colao A; Merola B; Longobardi S; Rossi E; Esposito V; Orio F; Lombardi G
    J Endocrinol Invest; 1995 Jan; 18(1):63-7. PubMed ID: 7759787
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clonidine potentiates the growth hormone response to a growth hormone releasing hormone challenge in hypothalamic growth hormone releasing hormone deficient rats.
    Arce V; García Barros M; Vara E; Lima L; Tresguerres JA; Devesa J
    Neuroendocrinology; 1995 May; 61(5):552-8. PubMed ID: 7617133
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of growth hormone (GH)-releasing hormone and somatostatin in the mediation of clonidine-induced GH release in sheep.
    Magnan E; Cataldi M; Guillaume V; Mazzocchi L; Dutour A; Razafindraibe H; Sauze N; Renard M; Oliver C
    Endocrinology; 1994 Feb; 134(2):562-7. PubMed ID: 7905408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blunted growth hormone response to peripheral infusion of human growth hormone-releasing factor in patients with panic disorder.
    Rapaport MH; Risch SC; Gillin JC; Golshan S; Janowsky DS
    Am J Psychiatry; 1989 Jan; 146(1):92-5. PubMed ID: 2492166
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blunted growth hormone response to clonidine in post-traumatic stress disorder.
    Morris P; Hopwood M; Maguire K; Norman T; Schweitzer I
    Psychoneuroendocrinology; 2004 Feb; 29(2):269-78. PubMed ID: 14604605
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.
    Cordido F; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1990 May; 70(5):1361-70. PubMed ID: 2159483
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interactions between the effects of opioid, serotonin and alpha-2-adrenergic receptor agonists on growth hormone release in the male rat. Intravenous administration.
    Chapman IM; Willoughby JO
    Neuroendocrinology; 1993 May; 57(5):912-20. PubMed ID: 8105397
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma homovanillic acid correlates inversely with history of childhood trauma in personality disordered and healthy control adults.
    Lee R; Coccaro EF
    J Neural Transm (Vienna); 2010 Nov; 117(11):1327-34. PubMed ID: 20953642
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blunted hormone responses to Ipsapirone are associated with trait impulsivity in personality disorder patients.
    Minzenberg MJ; Grossman R; New AS; Mitropoulou V; Yehuda R; Goodman M; Reynolds DA; Silverman JM; Coccaro EF; Marcus S; Siever LJ
    Neuropsychopharmacology; 2006 Jan; 31(1):197-203. PubMed ID: 16123761
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Catecholamine and HPA axis dysfunction in depression: relationship with suicidal behavior.
    Pitchot W; Reggers J; Pinto E; Hansenne M; Ansseau M
    Neuropsychobiology; 2003; 47(3):152-7. PubMed ID: 12759559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.